Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

16:20 EDT 29th May 2015 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 7,200+

Wednesday 27th May 2015

Gene Testing Can Be Flawed, Study Finds

WEDNESDAY, May 27, 2015 -- Gene tests that claim to predict your risk for certain diseases are often inaccurate, a large, new study finds. Errors in testing or interpretation are serious, possibly leading to unneeded treatment or deterring someone...

Calyxt Appoints Chief Financial Officer

Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products, today announced the appointment of Gregory R. Smith as Chief Financial Officer. With over 25 years in both public and private companies, Mr. Smith has served in various management roles including CFO and Vice President of Finance, with experience in financial s...

ArQule, Inc. to Present at Jefferies 2015 Global Healthcare Conference

ArQule, Inc. (Nasdaq: ARQL) today announced that the Company will present at the Jefferies 2015 Global Healthcare Conference on June 3, 2015 at 10:30 a.m. The presentation will be web cast and may be accessed through the investor relations section of the Company’s website, http://investors.arqule.com/. About ArQule ArQule is a biotechno...

La Jolla Pharmaceutical Company to Provide Corporate Overview at the Jefferies 2015 Global Healthcare Conference

La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that George F. Tidmarsh, M.D., Ph.D., President and Chief Executive Officer of La Jolla, will provide a corporat...

The 21st Century Cures Act: Unanimously Approved Leading to Hopeful Treatment Options for International Essential Tremor Foundation Patients

The 21st Century Cures provision, one of the International Essential Tremor Foundation's top advocacy issues, will help create incentives for pharmaceutical companies to pursue medications that currently don’t exist, are difficult to develop and costly to produce, but have the potential to improve the lives of millions of Americans living with chronic diseases and disabilities, like essentia...

Juno, Editas To Collaborate On CRISPR-Juiced Cancer Immunotherapy

The gene editing technology CRISPR-Cas9 might be prompting major ethical questions about its use in altering human intelligence and appearance, but biotech startups are now pushing it forward as a way to make better cancer therapies. In the second de...

Calimmune raises $15M in series B

Gene therapy company Calimmune Inc. (Tucson, Ariz.) raised $15 million in a series B round led by AbbVie Biotech Ventures Inc., the venture arm of AbbVie Inc. (NYSE:ABBV). New investor Alexandria Venture Investments and existing investors RA Capital ...

Juno, Editas to collaborate on CAR T therapies

Juno Therapeutics Inc. (NASDAQ:JUNO) and Editas Medicine (Cambridge, Mass.) partnered to develop chimeric antigen receptor (CAR) T cell and T cell receptor (TCR) therapies for cancer. The partners will develop three undisclosed programs using Juno's ...

Focus on the Broccoli Benefits rather than the Hamburger Harms

Tell your child or spouse what they can eat and not what they can't. Telling your child to eat an apple so they stay healthy will work better than telling them not to eat the cookie because it will make them fat. A new Cornell discovery shows that "D...

CAS Researchers Clone Heat Tolerance Gene from African Rice Variety

A team of scientists from the Chinese Academy of Sciences led by Lin Hongxuan successfully isolated and cloned heat tolerance genes from African rice strains, which could be used to develop rice varieties that can resist the effects of global warming.According to Lin, temperatures over 35 degrees Celsius decreased the productivity of rice plants. H...

Sex Determining Genes in Mosquitoes Could Help Fight Dengue Fever

Researchers at the Fralin Life Science Institute at Virginia Tech have identified a gene responsible for sex determination in mosquitoes that transmit yellow fever, dengue, and chikungunya viruses. The researchers identified a male-determining genetic switch called Nix in Aedes aegypti mosquitoes that underlies the difference between males and fema...

RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants

MARLBOROUGH, Mass., May 27, 2015 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology, today announced that it has commenced a public offering of shares of its common stock, warrants to purchase shares of its common stock and overallotment ...

OPKO Health to Present at the Jefferies 2015 Healthcare Conference

OPKO Health, Inc. (NYSE:OPK) today announced that senior management will present at the Jefferies 2015 Healthcare Conference on Wednesday, June 3, 2015 at 4:00 PM EDT in New York City. The presentation will be webcast on the OPKO Investor Relations page of the corporate website at www.opko.com. To access the live webcast please log on to the OPKO ...

Akron Biotech and Cognate BioServices Announce Strategic Partnership

Cognate BioServices, Inc. and Akron Biotechnology, LLC are pleased to announce a strategic partnership that brings two industry leaders together to provide a more complete package of services to their clients. Cognate is a leader in the provision of cGMP manufacturing services and regulatory support to companies and institutions engaged in the development ...

LumiThera Receives LSDF Commercialization Grant Award

SEATTLE, May 27, 2015 /PRNewswire/ -- LumiThera Inc., a developmental stage medical device company creating a non-invasive photobiomodulation (PBM) treatment for ocular disorders and disease, announced today that they were awarded a Washington State Life Sciences Discovery Fund (LSDF) commercialization grant. LumiThera was 1 of 3 recipients of the LSDF matching grants worth $500,000 to p...

CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy

Abstract Published at American Society of Clinical Oncology Annual Meeting; Illustrates Increased Survival Rate for Stage 1 Non-small Cell Lung Cancer Patients without Pharmacokinetic Gene Variant HOUSTON, Tx (PRWEB) May 27, 2015 CompanionDx announced that its abstract “Role of combined germline pharmacogenomic and somatic genomic analysis in personalized cancer therapy: Non-small cell lung can...

Gene therapy for HIV: Arizona startup Calimmune gets $15M Series B

The startup's gene therapy for HIV and AIDS spins out of the work from Nobel Laureate David Baltimore at CalTech. It's using the funding to further Phase I/II clinical trials.

Health Highlights: May 27, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: White House Puts Hold on Type of Gene Engineering Genetic engineering that makes DNA changes that are passed along to future generations should...

IMS Health AppScript Now Available to Healthcare Professionals on QuantiaMD

Leading Discovery and Distribution Platform for Mobile Health Technologies to be Featured within Active Web and Mobile Physician Community Quantia, Inc., the Physician Engagement Platform, and

Mice Lacking the Serotonin Htr2B Receptor Gene Present an Antipsychotic-Sensitive Schizophrenic-Like Phenotype

Researchers oppose unvalidated gene panel tests for cancer links

CHICAGO, May 27 (Reuters) - A group of international researchers is making the case that genetic tests that look for multiple hereditary genes suspected of being linked to breast cancer should not be offered until they are proven to be valid and usef...

Memorial Sloan Kettering Cancer Center Selects PDS Life Sciences’ Ascentos™ Software for Preclinical Research

PDS Life Sciences, a leading global provider of intuitive data management software and solutions for life sciences research, announced that Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, h

Beryllium Develops an MCL-1 Platform for Structure-Guided Drug Discovery in Collaboration with the Broad Institute

Research details are published in a recent issue of PLOS One Beryllium, a scientific research services company engaging in collaborations with commercial and academic partners, today announced the development of an MCL-1 platform for structure-guided drug discovery. MCL-1 is one of the top-ten most amplified genes in all of human cancer and is vital to...

Calimmune Completes $15 Million Series B Financing

Proceeds Will Advance Clinical Trials for Gene-Based HIV/AIDS Therapies Calimmune Inc., a clinical-stage gene therapy company, has successfully completed its $15 million Series B financing round, led by a large pharmaceutical company. Alexandria Venture Investments also joined with existing investors including RA Capital Healthcare Fund LP and T...

Cellecta – functional screening and drug target discovery

Cellecta is a biotech company developing advanced high-throughput genetic screen technologies for the discovery and functional characterization of novel therapeutic targets and drugs. Cellecta – functional screening and drug target discovery Cellecta offers highly customized contract research services to develop … Continue reading → Cet article Cellecta – functional screeni...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks